+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro



The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro



Cancer ChemoTherapy and Pharmacology 22(3): 197-200



The effects of the antitumor antibiotic, quinocarmycin citrate (KW 2152), on L1210 cells were studied in vitro. The cellular growth was completely inhibited at 10(-6) M KW 2152, and after 2 days no viable cell was seen. The incorporation of 3H-thymidine, 3H-uridine, or 3H-leucine into the acid-insoluble fraction was not affected at 10(-4) M for 1 h; however, when the cells were treated with 10(-6) M for 24 h, the radioactivity appearing in the acid-insoluble fraction was reduced to 20%, 30%, and 48%, respectively, of the control. The single strand scission of the DNA of L1210 cells was seen at 10(-7) M for 24 h, as revealed by an alkaline, sucrose density gradient. However, no damage to plasmid pBR322 was observed even at 10(-6) M KW 2152 for 24 h, as revealed by 0.8% agarose gel electrophoresis, indicating that some soluble factors of the cells might contribute to the damage to the DNA of L1210 cells. The processing of pre-rRNA of the cells was not inhibited at 10(-6) M of the drug for 24 h of incubation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041690964

Download citation: RISBibTeXText

PMID: 3409454

DOI: 10.1007/bf00273410


Related references

Antitumor activity of quinocarmycin kw 2152 against various cultured leukemia and lymphoma cells lines in vitro. Cancer Research 48(21): 6029-6032, 1988

Antitumor activity of quinocarmycin citrate (KW-2152) against human tumor xenografts serially transplanted into nude mice. Keio Journal of Medicine 37(4): 355-364, 1988

Novel antitumor antibiotics kw 2152 quinocarcin citrate antitumor activity and mechanism of action. Proceedings of the American Association for Cancer Research Annual Meeting 27: 275, 1986

Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells. Neoplasma 33(1): 3, 1986

Mechanistic aspects of the cytocidal action of ulithiacyclamide on mouse leukemia L1210 cells in vitro. Biochemical Pharmacology 38(24): 4497-4500, 1989

The cytostatic effects and mechanism of action of antiviral acyclic adenine nucleotide analogs in L1210 mouse leukemia cells. Neoplasma 37(2): 105-110, 1990

Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. Journal of Cellular Physiology 107(2): 283-293, 1981

The effect of citrate and other compounds on PMN incubated in vitro: further studies on the site and mechanism of action of citrate. Cornea 3(4): 240-249, 1984

Metabolism of retinaldehyde in intact mouse l1210 lymphocytic leukemia cells that lack l1210 0 or contain l1210 oap aldehyde dehydrogenase 2 ahd 2. Proceedings of the American Association for Cancer Research Annual Meeting 33: 26, 1992

Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L1210 leukemia in vitro. Cancer Research 20: 225-232, 1960

Mechanism of action of arenesulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide in L1210 cells. Cancer Research 44(12 Pt 1): 5707-5711, 1984

Studies on the mechanism of action of 3 deazaguanine 3dg in murine l1210 cells. FASEB Journal 2(5): ABSTRACT 6146, 1988

Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells. Progress in Clinical and Biological Research 132b: 415-423, 1983

Cytotoxicity assays with L1210 cells in vitro: comparison with L1210 in vivo and KB cells in vitro. Cancer ChemoTherapy Reports. Part 2 2(1): 1-25, 1971